Use of broad-spectrum antibiotics in six non-university Swiss hospitals
Author(s) -
Vera von Gunten,
Jean-Philippe Reymond,
Nicolas Troillet
Publication year - 2001
Publication title -
schweizerische medizinische wochenschrift
Language(s) - English
Resource type - Journals
ISSN - 0036-7672
DOI - 10.4414/smw.2001.09760
Subject(s) - medicine , cefepime , imipenem , piperacillin , tazobactam , meropenem , ceftazidime , piperacillin/tazobactam , formulary , antibiotics , intensive care medicine , emergency medicine , pharmacology , microbiology and biotechnology , antibiotic resistance , bacteria , genetics , pseudomonas aeruginosa , biology
Broad-spectrum antibiotics (BSAs) are costly and prone to misuse. Their use is associated with the emergence of resistant bacteria. This article describes the first step of an interhospital programme for the appropriate use of BSAs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom